Campbell & CO Investment Adviser LLC Clovis Oncology, Inc. Transaction History

Campbell & CO Investment Adviser LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 23, 2020	SELL	$3.0 - $16.43 $30,306 - $165,975	-10,102 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$3.93 - $15.35 $59,602 - $232,798	-15,166 Reduced 60.02%	10,102 $40,000
Q2 2019 Jul 10, 2019	BUY	$12.81 - $25.67 $323,683 - $648,629	25,268 New	25,268 $376,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.